DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

NCT06953089 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

492

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: DB-1311/BNT324
DRUG: BNT327
DRUG: DB-1305/BNT325

Sponsor

DualityBio Inc.

Collaborators

[object Object]